GLP-1
AstraZeneca/ Diabetes/ Diabetes/ News/ News/ R&D/ UK & Europe
AstraZeneca improves diabetes pen to maintain its market share
Diabetes/ Diabetes/ News/ News/ News/ Novo Nordisk/ Patients/ R&D/ Top pharmaceutical companies/ Top stories
Novo’s diabetes pill beats injections in head-to-head trials
Piotr Wnuk
Diabetes, diabetes care, GLP-1, Insuline, Januvia, Novo Nordisk, semaglutide, Sitagliptin, Type 2 diabetes, Victoza
0 Comment
Articles/ Novo Nordisk/ Views and analysis
The ‘game changers’ in diabetes: Novo and Lilly battle it out
Andrew McConaghie
Diabetes, EASD, GLP-1, Novo Nordisk, Victoza
0 Comment
Sanofi GLP-1 finally approved in US
Richard Staines
Diabetes, GLP-1, Sanofi
0 Comment
But can it seriously challenge Novo Nordisk rival?
Sanofi’s diabetes combo on target for showdown with Novo
Richard Staines
Diabetes, GLP-1, insulin, Novo Nordisk, Sanofi
0 Comment
Rival insulin and GLP-1 combinations under review in US.